Risk stratification in anti‐ MDA5 + dermatomyositis‐related interstitial lung disease by using cluster analysis
Journal of the European Academy of Dermatology and Venereology · 2026-03 · 40 (3) · 446-454
DOI: 10.1111/jdv.20850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 18.07.2025. Verfasst von Wenzhang He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial, Interferon-Induced Helicase, IFIH1, Autoantibodies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Anti‐MDA5+ dermatomyositis (DM) represents a heterogeneous group of patients as diverse individuals display different clinical characteristics, disease progression and complications development. The heterogeneity makes it difficult to classify interstitial lung disease in anti‐MDA5 antibodies positive dermatomyositis (anti‐MDA5+ DM‐ILD).
Objectives
To distinguish and characterize phenotypic subgroups for anti‐MDA5+ DM‐ILD patients.
Methods
From August 2014 to March 2022, 188 anti‐MDA5+ DM‐ILD patients were retrospectively enrolled. 21 HRCT‐derived quantitative features were reduced to four principal components through principal component analysis. The missForest algorithm was employed for missing data imputation. Clusters were determined by partitioning around medoids. The classification and regression tree (CART) algorithm was utilized to distinguish between three clusters.
Results
The Silhouette Coefficient and Dunn index indicated an optimal cluster number of 3. Patients in cluster 2 (high‐risk cluster) have the highest RP‐ILD incidence rate (84.9% vs. 18.1% vs. 17.1%, cluster 2 vs. 1 vs. 3, p < 0.001), extremely high early mortality (88.7% vs. 4.3% vs. 2.4%, cluster 2 vs. 1 vs. 3, p < 0.001) and moderate dermato‐rheumatologic pattern. Patients in cluster 1 correspond to a pure dermato‐rheumatologic pattern (dermato‐rheumatologic cluster). Cluster 3 (low‐risk cluster) was characterized by not obvious dermato‐rheumatologic and the lowest RP‐ILD incidence (17.1%) as well as the lowest early mortality (2.4%). The accuracy of the CART algorithm in differentiating clusters was 67.7% in the validation cohort with 56 patients. Principal component 1 was a key feature in the CART algorithm. Sensitivity analyses employing multiple clustering approaches confirmed the robustness of the three‐cluster solution by partitioning around medoids.
Conclusions
Clustering analysis offers valuable insights into the heterogeneity and clinical implications of anti‐MDA5+ DM‐ILD. HRCT‐derived quantitative features demonstrate significant value for early risk stratification in anti‐MDA5+ DM‐ILD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
- Department of Radiology, Chongqing General Hospital, Chongqing University, Chongqing, China.
- Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, China.
- Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Biomedical Big Data Center, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China.
- Medical Imaging Center, West China Lecheng Hospital, Sichuan University, Qionghai, China.
ORCID-Profile: Beibei Cui, Liqing Peng
Förderung
- Science and Technology Department of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
He, W., Cui, B., Chu, Z., Huang, X., Liu, J., Li, X., Wang, Y., Pang, X., Lin, H., & Peng, L. (2026). Risk stratification in anti‐ MDA5 + dermatomyositis‐related interstitial lung disease by using cluster analysis. Journal of the European Academy of Dermatology and Venereology, 40(3), 446-454. https://doi.org/10.1111/jdv.20850
Vancouver
He W, Cui B, Chu Z, Huang X, Liu J, Li X, et al. Risk stratification in anti‐ MDA5 + dermatomyositis‐related interstitial lung disease by using cluster analysis. Journal of the European Academy of Dermatology and Venereology. 2026;40(3):446-454. doi:10.1111/jdv.20850
BibTeX
@article{He2026,
author = {He, Wenzhang and Cui, Beibei and Chu, Zhigang and Huang, Xuan and Liu, Jing and Li, Xue and Wang, Yinqiu and Pang, Xueting and Lin, Hui and Peng, Liqing},
title = {Risk stratification in anti‐ MDA5 + dermatomyositis‐related interstitial lung disease by using cluster analysis},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
volume = {40},
number = {3},
pages = {446--454},
doi = {10.1111/jdv.20850}
}
EUVIMED